| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/NEN.0B013E3181F97392 |
| P698 | PubMed publication ID | 20940628 |
| P50 | author | Neil Scolding | Q79652575 |
| P2093 | author name string | David Gordon | |
| James B Uney | |||
| David C Wraith | |||
| Gordana Pavlovska | |||
| P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| Adult bone marrow stromal cells differentiate into neural cells in vitro | Q28142055 | ||
| Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons | Q28367760 | ||
| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
| Mesenchymal stem cells: biology and potential clinical uses | Q34034011 | ||
| Differentiation potential of adult stem cells | Q34353171 | ||
| New concepts in the immunopathogenesis of multiple sclerosis | Q34609924 | ||
| Pathogenesis of multiple sclerosis: an update on immunology | Q34667947 | ||
| Adult stem cell plasticity | Q34736836 | ||
| Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon | Q35594665 | ||
| IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE | Q36103132 | ||
| Circulating skeletal stem cells | Q36326343 | ||
| Immunoregulatory function of mesenchymal stem cells | Q36609696 | ||
| Remyelination of the spinal cord following intravenous delivery of bone marrow cells | Q37020042 | ||
| Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord | Q37020073 | ||
| Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. | Q37253314 | ||
| The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group | Q37677911 | ||
| Stem cell transplantation in multiple sclerosis: current status and future prospects | Q37734210 | ||
| Remyelination is extensive in a subset of multiple sclerosis patients. | Q40295868 | ||
| Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells | Q40317890 | ||
| Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation | Q40600413 | ||
| Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration | Q42828754 | ||
| Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration | Q43195511 | ||
| In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. | Q43550892 | ||
| Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats | Q43727683 | ||
| Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease | Q43822209 | ||
| Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro | Q44085388 | ||
| Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery | Q44115092 | ||
| Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease | Q45863206 | ||
| Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness | Q45879145 | ||
| Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice | Q46499204 | ||
| Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 | ||
| Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis | Q46940191 | ||
| Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. | Q47586113 | ||
| Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. | Q47894301 | ||
| Axonal swellings and degeneration in mice lacking the major proteolipid of myelin | Q48004959 | ||
| Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis | Q48227850 | ||
| Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | Q48332405 | ||
| Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival | Q48371412 | ||
| Axon loss in multiple sclerosis. | Q48405586 | ||
| Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
| Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. | Q50632074 | ||
| Enhanced green fluorescent protein-expressing human mesenchymal stem cells retain neural marker expression. | Q50655063 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Human mesenchymal stem cells signals regulate neural stem cell fate. | Q51091114 | ||
| New cells from old. | Q53496415 | ||
| P433 | issue | 11 | |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | 1087-1095 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
| P1476 | title | Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis | |
| P478 | volume | 69 |
| Q42511103 | Adipose tissue-derived stromal cells (ADSC) express oligodendrocyte and myelin markers, but they do not function as oligodendrocytes |
| Q59355284 | Beneficial and detrimental impact of transplanted canine adipose-derived stem cells in a virus-induced demyelinating mouse model |
| Q47619959 | Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases |
| Q47885870 | Cell-based therapeutic strategies for multiple sclerosis |
| Q36861620 | Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis |
| Q39444572 | Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells isolated from experimental autoimmune encephalomyelitis mice. |
| Q30437823 | Clinical applications of mesenchymal stem cells in chronic diseases |
| Q37080676 | Comparative Effects of Human Neural Stem Cells and Oligodendrocyte Progenitor Cells on the Neurobehavioral Disorders of Experimental Autoimmune Encephalomyelitis Mice |
| Q39356461 | Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases |
| Q44345787 | Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis. |
| Q90153784 | Diffuse white matter response in trauma-injured brain to bone marrow stromal cell treatment detected by diffusional kurtosis imaging |
| Q35788582 | Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination. |
| Q36187725 | Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination |
| Q34903919 | Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination |
| Q50532130 | Endothelial Progenitor Cell Secretome and Oligovascular Repair in a Mouse Model of Prolonged Cerebral Hypoperfusion. |
| Q36615147 | Engineering an in situ crosslinkable hydrogel for enhanced remyelination. |
| Q35589934 | Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). |
| Q47976872 | FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential |
| Q35603241 | Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis |
| Q41900937 | Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis |
| Q37702208 | In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence. |
| Q38957213 | Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model. |
| Q43420102 | Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice |
| Q88504806 | Mesenchymal Stem Cells Form 3D Clusters Following Intraventricular Transplantation |
| Q34950646 | Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation |
| Q34053510 | Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts |
| Q98177558 | Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis |
| Q30590258 | Primary progressive multiple sclerosis: progress and challenges. |
| Q28482227 | Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation |
| Q40266592 | Rat BMSC infusion was unable to ameliorate inflammatory injuries in tissues of mice with LPS-induced endotoxemia |
| Q91761207 | Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study |
| Q39616072 | Stem Cells Therapy in Multiple Sclerosis - A New Hope for Progressive Forms |
| Q48450832 | Stem cell therapy in multiple sclerosis: a future perspective |
| Q26823691 | The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS) |
| Q37982954 | The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis. |
| Q59001351 | Translational Research in Stem Cell Treatment of Neuromuscular Diseases |
| Q37499253 | Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model |
| Q48501595 | Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis |
Search more.